Article
[Leptin, adiponectin, lipodystrophic and severe insulin resistance syndromes].
Annales de biologie clinique - 1 Jun 2020
Vatier Camille, Jéru Isabelle, Fellahi Soraya, Capeau Jacqueline, Bastard Jean-Philippe, Vigouroux Corinne
Abstract excerpt
Leptin and adiponectin are two adipokines currently used as biomarkers for diagnostic orientation and phenotyping in syndromes of lipodystrophy and severe insulin resistance. The level of these biomarkers also has an impact on the therapeutic management of the patients. These aspects, as well as our experience as a reference center, are described in this brief overview.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
